07:00 , Jun 25, 2012 |  BC Week In Review  |  Company News

Prolias Technologies, Cornell University deal

The university granted Prolias Technologies exclusive, worldwide rights to IP related to microRNA diagnostics developed at the Weill Cornell Medical College . The IP includes a miRNA panel to differentiate malignant and benign indeterminate thyroid...